Polysilsesquioxane nanoparticles for triggered release of cisplatin and effective cancer chemoradiotherapy
about
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) ProdrugsHybrid nanoparticles for combination therapy of cancerThermosensitive Hydrogel Co-loaded with Gold Nanoparticles and Doxorubicin for Effective ChemoradiotherapyAn interdisciplinary computational/experimental approach to evaluate drug-loaded gold nanoparticle tumor cytotoxicity.Electrohydrodynamic fabrication of core-shell PLGA nanoparticles with controlled release of cisplatin for enhanced cancer treatment.Nanoparticle formulations of cisplatin for cancer therapy.Chemistry of Mesoporous Organosilica in Nanotechnology: Molecularly Organic-Inorganic Hybridization into Frameworks.Organosilica hybrid nanomaterials with a high organic content: syntheses and applications of silsesquioxanes.Targeted nanoparticle for head and neck cancers: overview and perspectives.Emerging Nanotechnology and Advanced Materials for Cancer Radiation Therapy.In vitro evaluation of folic acid-conjugated redox-responsive mesoporous silica nanoparticles for the delivery of cisplatin.Dual-Drug Containing Core-Shell Nanoparticles for Lung Cancer TherapyPhosphatase-triggered cell-selective release of a Pt(iv)-backboned prodrug-like polymer for an improved therapeutic index.Quantification of endocytosis using a folate functionalized silica hollow nanoshell platform.Metal-based NanoEnhancers for Future Radiotherapy: Radiosensitizing and Synergistic Effects on Tumor Cells.
P2860
Q28066801-C7897720-CD55-4961-ADE4-CEE65AB58C18Q28086815-3A0CD220-E090-4433-B058-4392E6623551Q36445146-E18C1550-320D-4F7D-857E-8364B93BC141Q37013368-636957AB-8394-4E5A-A552-ABFC811356BEQ38701292-BD666728-C4C1-4CA3-99BF-F882E5EC715BQ38723829-510AFA7D-2322-4C4B-9CEF-99A4AC3C3F5AQ38758605-0E73858D-45B7-494B-AA90-BABBCF99722DQ39023379-4403F563-21B2-4B73-88F3-CEAAF89004BFQ39226270-B16BC3AB-7F14-4388-B982-F4355E6CED22Q39393466-F2E68E91-9D54-460F-A569-5826331F8218Q42362653-3ECE0084-A352-4414-8118-F4186F2C8E31Q42379033-B695767A-111D-4435-A885-E86991D74296Q48258055-C47CA300-9CA4-4072-8E08-3D011D164FE2Q51792729-7F5A90C0-8CF9-455F-9B14-706E3A40FD25Q52647643-EAB00158-EB9D-4C5A-88E9-C01A35E472D2
P2860
Polysilsesquioxane nanoparticles for triggered release of cisplatin and effective cancer chemoradiotherapy
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Polysilsesquioxane nanoparticl ...... ctive cancer chemoradiotherapy
@ast
Polysilsesquioxane nanoparticl ...... ctive cancer chemoradiotherapy
@en
Polysilsesquioxane nanoparticl ...... ctive cancer chemoradiotherapy
@nl
type
label
Polysilsesquioxane nanoparticl ...... ctive cancer chemoradiotherapy
@ast
Polysilsesquioxane nanoparticl ...... ctive cancer chemoradiotherapy
@en
Polysilsesquioxane nanoparticl ...... ctive cancer chemoradiotherapy
@nl
prefLabel
Polysilsesquioxane nanoparticl ...... ctive cancer chemoradiotherapy
@ast
Polysilsesquioxane nanoparticl ...... ctive cancer chemoradiotherapy
@en
Polysilsesquioxane nanoparticl ...... ctive cancer chemoradiotherapy
@nl
P2093
P2860
P1476
Polysilsesquioxane nanoparticl ...... ctive cancer chemoradiotherapy
@en
P2093
Joseph Della Rocca
Juan L Vivero-Escoto
Michael E Werner
Natalie D Cummings
Rachel C Huxford-Phillips
Rohit Sukumar
Stephanie A Kramer
Wenbin Lin
P2860
P356
10.1016/J.NANO.2014.07.004
P50
P577
2014-07-17T00:00:00Z